F Ivy Carroll (F I Carroll)

Publication Activity (10 Years)

Years Active: 2015-2022
Publications (10 Years): 8

Top Topics

Clinical Evaluation

Binding Protein

Diabetic Retinopathy

Top Venues

Journal of medicinal chemistry

ACS chemical neuroscience

Annals of the New York Academy of Sciences

Acta crystallographica. Section D, Structural biology

This page only lists publications with an associated author ORCID identifier.

Publications

Renata V Bueno, Samuel Davis, Alice Dawson, Pauline W Ondachi, F Ivy Carroll, William N Hunter
Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta crystallographica. Section D, Structural biology 78 (Pt 3) (2022)
Tao Che, Justin G English, Brian E Krumm, Kuglae Kim, Els Pardon, Reid H J Olsen, Sheng Wang, Shicheng Zhang, Jeffrey F Diberto, Noah Sciaky, F Ivy Carroll, Jan Steyaert, Daniel Wacker, Bryan L Roth
Nanobody-enabled monitoring of kappa opioid receptor states. Nature communications 11 (1) (2020)
F Ivy Carroll, Anita H Lewin, S Wayne Mascarella, Herbert H Seltzman, P Anantha Reddy
Designer drugs: a medicinal chemistry perspective (II). Annals of the New York Academy of Sciences 1489 (1) (2020)
Federico Baruffaldi, M D Raleigh, S J King, M J Roslawski, A K Birnbaum, C Hassler, F Ivy Carroll, S P Runyon, S Winston, P R Pentel, Marco Pravetoni
Formulation and Characterization of Conjugate Vaccines to Reduce Opioid Use Disorders Suitable for Pharmaceutical Manufacturing and Clinical Evaluation. Molecular pharmaceutics 16 (6) (2019)
Pauline W Ondachi, Chad M Kormos, Scott P Runyon, James B Thomas, S Wayne Mascarella, Ann M Decker, Hernán A Navarro, Timothy R Fennell, Rodney W Snyder, F Ivy Carroll
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic). Journal of medicinal chemistry 61 (17) (2018)
Chad M Kormos, Pauline W Ondachi, Scott P Runyon, James B Thomas, S Wayne Mascarella, Ann M Decker, Hernán A Navarro, Timothy R Fennell, Rodney W Snyder, F Ivy Carroll
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic). Journal of medicinal chemistry 61 (17) (2018)
Anita H Lewin, Larry Brieaddy, Jeffrey R Deschamps, Gregory H Imler, S Wayne Mascarella, P Anantha Reddy, F Ivy Carroll
Synthesis and Characterization of the Selective, Reversible PKCβ Inhibitor (9 S)-9-[(Dimethylamino)methyl]-6,7,10,11-tetrahydro-9 H,18 H-5,21:12,17-dimethenodibenzo[ e,k]pyrrolo[3,4- h][1,4,13]oxadiazacyclohexadecine-18,20(19 H)-dione, Ruboxistaurin (LY333531). ACS chemical neuroscience 10 (1) (2018)
Anita H Lewin, Scott E Fix, Desong Zhong, Louise D Mayer, Jason P Burgess, S Wayne Mascarella, P Anantha Reddy, Herbert H Seltzman, F Ivy Carroll
Caged Naloxone: Synthesis, Characterization, and Stability of 3- O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX). ACS chemical neuroscience 9 (3) (2017)
Steven D Chang, S Wayne Mascarella, Skylar M Spangler, Vsevolod V Gurevich, Hernan A Navarro, F Ivy Carroll, Michael R Bruchas
Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. Molecular pharmacology 88 (3) (2015)